Type 2 Diabetes Mellitus non-surgical remission: A possible mission

被引:7
作者
Allam, Magdy M. [1 ]
El-Zawawy, Hanaa T. [2 ]
机构
[1] Alexandria Univ, AUSH, Internal Med Dept, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Endocrinol Unit, Internal Med Dept, Alexandria, Egypt
关键词
Diabetes Mellitus; Remission; Vildagliptin; BARIATRIC SURGERY; ASSOCIATION;
D O I
10.1016/j.jcte.2019.100206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Remission of Type 2 Diabetes Mellitus (DM) has been observed throughout the last few years, yet factors associated with remission through non-surgical approaches are still unclear. So, the factors associated with type 2 DM remission were investigated. Methods: Out 670 patients, 63 patients gained non-surgical remission of type 2 DM (defined according to ADA criteria), and 396 patients served as control matched for age, sex, and BMI. The records of patients who attended Alexandria University Students Hospital between the years 2015 and 2018 were reviewed retrospectively. The collected data at first visit and 1 year after remission were history, examination, HbA1c %, oral glucose tolerance test & fasting blood glucose and lipid profile and type of treatment. Results: 75% of patients were females with mean age 51.5 +/- 11.34 years. The mean duration of treatment fill remission was 26.4 +/- 33.1 months. One year after remission HbA1c & BMI were significantly decreased (P = 0.001, 0.03; respectively). However, cox proportional hazards model & ROC curve analysis showed that age < 50 years, female sex, short duration of diabetes < 5.2 years, intial HbA1c < 8.5%, HDL > 45.6 mg/dl, and initial intervention with lifestyle modification, 2000 mg metformin and 100 mg vildagliptin are the factors associated with remission. Conclusion: Our mission in type 2 DM female patients < 50 years with short duration of disease < 5.2 years, initial HbA1c < 8.5% and HDL > 45.6 mg/dl, is to achieve diabetes remission by intensive life style modification with daily metformin and vildagliptin.
引用
收藏
页数:5
相关论文
共 13 条
  • [1] How Do We Define Cure of Diabetes?
    Buse, John B.
    Caprio, Sonia
    Cefalu, William T.
    Ceriello, Antonio
    Del Prato, Stefano
    Inzucchi, Silvio E.
    McLaughlin, Sue
    Phillips, Gordon L., II
    Robertson, R. Paul
    Rubino, Francesco
    Kahn, Richard
    Kirkman, M. Sue
    [J]. DIABETES CARE, 2009, 32 (11) : 2133 - 2135
  • [2] Lifestyle Management: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S46 - S60
  • [3] Serum leptin in male hypothyroid prediabetic patients: Association with cardiovascular risk
    El-Zawawy, Hanaa T.
    [J]. CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (04) : 84 - 87
  • [4] Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
    Gregg, Edward W.
    Chen, Haiying
    Wagenknecht, Lynne E.
    Clark, Jeanne M.
    Delahanty, Linda M.
    Bantle, John
    Pownall, Henry J.
    Johnson, Karen C.
    Safford, Monika M.
    Kitabchi, Abbas E.
    Pi-Sunyer, F. Xavier
    Wing, Rena R.
    Bertoni, Alain G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (23): : 2489 - 2496
  • [5] 10-year follow-up of intensive glucose control in type 2 diabetes
    Holman, Rury R.
    Paul, Sanjoy K.
    Bethel, M. Angelyn
    Matthews, David R.
    Neil, H. Andrew W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) : 1577 - 1589
  • [6] Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study
    Karter, Andrew J.
    Nundy, Shantanu
    Parker, Melissa M.
    Moffet, Howard H.
    Huang, Elbert S.
    [J]. DIABETES CARE, 2014, 37 (12) : 3188 - 3195
  • [7] Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
    Lean, Michael E. J.
    Leslie, Wilma S.
    Barnes, Alison C.
    Brosnahan, Naomi
    Thom, George
    McCombie, Louise
    Peters, Carl
    Zhyzhneuskaya, Sviatlana
    Al-Mrabeh, Ahmad
    Hollingsworth, Kieren G.
    Rodrigues, Angela M.
    Rehackova, Lucia
    Adamson, Ashley J.
    Sniehotta, Falko F.
    Mathers, John C.
    Ross, Hazel M.
    McIlvenna, Yvonne
    Welsh, Paul
    Kean, Sharon
    Ford, Ian
    McConnachie, Alex
    Messow, Claudia-Martina
    Sattar, Naveed
    Taylor, Roy
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (05) : 344 - 355
  • [8] Saxagliptin Induces β-Cell Proliferation through Increasing Stromal Cell-Derived Factor-1α In Vivo and In Vitro
    Li, Chun-Jun
    Sun, Bei
    Fang, Qian-Hua
    Ding, Min
    Xing, Yun-Zhi
    Chen, Li-Ming
    Yu, De-Min
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [9] Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
    Mingrone, Geltrude
    Panunzi, Simona
    De Gaetano, Andrea
    Guidone, Caterina
    Iaconelli, Amerigo
    Leccesi, Laura
    Nanni, Giuseppe
    Pomp, Alfons
    Castagneto, Marco
    Ghirlanda, Giovanni
    Rubino, Francesco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (17) : 1577 - 1585
  • [10] Predictive Factors of Type 2 Diabetes Remission 1 Year After Bariatric Surgery: Impact of Surgical Techniques
    Robert, M.
    Ferrand-Gaillard, C.
    Disse, E.
    Espalieu, P.
    Simon, C.
    Laville, M.
    Gouillat, C.
    Thivolet, C.
    [J]. OBESITY SURGERY, 2013, 23 (06) : 770 - 775